Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,767 public trials 879 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Active, not recruiting

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

NCT05039840

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Accel Research Sites Network - Birmingham- Site Number : 8400003 Vestavia Hills, Alabama, United States
  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler- Site Number : 8400026 Chandler, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates - South Vineyard Avenue- Site Number : 8400022 Mesa, Arizona, United States
  • Arizona Arthritis & Rheumatology Research - Sun City- Site Number : 8400027 Sun City, Arizona, United States
View all 73 locations
View Trial Details
Active, not recruiting

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

NCT07015983

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Local Institution - 0106 Phoenix, Arizona, United States
  • Local Institution - 0038 Los Angeles, California, United States
  • Local Institution - 0051 Los Angeles, California, United States
  • Local Institution - 0093 Newport Beach, California, United States
View all 97 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

NCT03725007

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Duplicate_University of Louisville /ID# 202896 Louisville, Kentucky, United States
  • Boston Children's Hospital /ID# 202993 Boston, Massachusetts, United States
  • Cincinnati Childrens Hospital Medical Center /ID# 209697 Cincinnati, Ohio, United States
  • Randall Children's Hospital /ID# 213609 Portland, Oregon, United States
View all 35 locations
View Trial Details
Active, not recruiting

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

NCT05869955

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
Locations
  • Local Institution - 0035 Aurora, Colorado, United States
  • Local Institution - 0024 Denver, Colorado, United States
  • Local Institution - 0006 Jacksonville, Florida, United States
  • Local Institution - 0056 Miami, Florida, United States
View all 46 locations
View Trial Details
Active, not recruiting

Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus

NCT06333483

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Hospital Universitari Vall Hebrón Barcelona, Spain
  • Hospital Universitari i Politecnic La Fe Valencia, Spain
  • Addenbrookes Hospital Cambridge, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, United Kingdom
View Trial Details
Active, not recruiting

Nipocalimab in Moderate to Severe Sjogren's Disease

NCT06741969

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Advanced Clinical Research Center Chula Vista, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Arthritis & Osteoporosis Medical Center - La Palma La Palma, California, United States
  • NovaMed Research Monterey Park, California, United States
View all 254 locations
View Trial Details
Active, not recruiting

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site Glendale, Arizona, United States
  • Research Site La Palma, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Upland, California, United States
View all 164 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

NCT07266090

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • The First Affiliated Hospital Of Jinan University Guangzhou, Guangdong, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • First Affiliated Hospital of Henan University of Science and Technology Luoyang, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Active, not recruiting

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

NCT04877691

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Paradise Valley, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site El Cajon, California, United States
View all 140 locations
View Trial Details

Related conditions